International Chronic Myeloid Leukemia Pediatric Study (ICMLPed)
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
Sponsor: CIC Inserm 1402
This observational or N/A phase trial investigates Chronic Myeloid Leukemia and is currently actively recruiting participants. CIC Inserm 1402 leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2022 — Feb 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Unknown Status
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Unknown Status NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CIC Inserm 1402
- Imperial College London
- International BFM Study Group
- Poitiers University Hospital
- University Hospital Dresden
- University Medical Center Groningen
- University of Liege
- University of Milano Bicocca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Athens, Greece , Beirut, Lebanon , Bratislava, Slovakia , Copenhagen, Denmark , Dresden, Germany , Ghent, Belgium , Görükle, Turkey (Türkiye) , Hong Kong, China , Minsk, Belarus , North Adelaide, Australia and 10 more locations